Benchmarking the quality of care for ventilated patients has been an elusive goal for
regulators and quality advocates for many years. The VAP rate is the usual metric proposed …

Background Ventilator-associated pneumonia (VAP) surveillance is time consuming,
subjective, inaccurate, and inconsistently predicts outcomes. Shifting surveillance from …

Background. Hospitals and quality improvement agencies are vigorously focusing on
reducing rates of hospital-acquired infection. Ventilator-associated pneumonia (VAP) is …

In 2013, the United States Centers for Disease Control and Prevention redefined
surveillance for quality of care in ventilated patients by shifting from ventilator-associated …

Background Ventilator-associated conditions (VACs) and infection-related ventilator-
associated complications (iVACs) are the Centers for Disease Control and Prevention's new …

This article is an executive summary of a report from the Centers for Disease Control and
Prevention Ventilator-Associated Pneumonia Surveillance Definition Working Group …

BACKGROUND: The Centers for Disease Control and Prevention recently released a
surveillance definition for respiratory complications in ventilated patients, ventilator …

Objectives: The subjectivity and complexity of surveillance definitions for ventilator-
associated pneumonia preclude meaningful internal or external benchmarking and …

The increasing mismatch between surveillance rates and clinical diagnoses limits the utility
of official VAP rates to estimate disease burden and guide quality improvement. Advocates …

Introduction Ventilator-associated pneumonia (VAP) is a common cause of nosocomial
infection, and is related to significant utilization of health-care resources. In the past decade …